On the other hand, when two mito E3s act as tumor suppressors (such as in thyroid cancer for RNF185 and MUL1), induction of both enzymes could achieve a synergistic effect on cancer inhibition. The gene discussed is MUL1; the disease is thyroid gland carcinoma.